Zoetis (ZTS) Construction in Progress (2012 - 2025)
Zoetis' (ZTS) quarterly Construction in Progress came in at $1.3 billion in Q4 2025, down 4.29% year-over-year from $1.4 billion in Q4 2024, and down 4.29% quarter-over-quarter from $1.4 billion in Q4 2024.
Analysis
Zoetis (ZTS) Construction in Progress (2012 - 2025) Analysis & Trends
Zoetis (ZTS) has reported Construction in Progress for 14 consecutive years, with $1.3 billion the latest figure, recorded in Q4 2025.
- On a quarterly basis, Construction in Progress fell 4.29% year-over-year to $1.3 billion in Q4 2025; TTM through Dec 2025 was $1.3 billion, a 4.29% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 4.29% from the prior year.
- Construction in Progress was $1.3 billion for Q4 2025 at Zoetis, down from $1.4 billion in the prior quarter.
- Over five years, Construction in Progress peaked at $1.4 billion in Q4 2024 and troughed at $742.0 million in Q4 2021.
- A 5-year average of $1.1 billion and a median of $1.1 billion in 2023 frame the typical range for Construction in Progress.
- Across the five-year window, Construction in Progress soared 33.29% in 2023 and declined 4.29% in 2025, its largest moves.
- Over 5 years, Construction in Progress stood at $742.0 million in 2021, then rose by 9.7% to $814.0 million in 2022, then soared by 33.29% to $1.1 billion in 2023, then advanced by 24.7% to $1.4 billion in 2024, then retreated by 4.29% to $1.3 billion in 2025.
- The last three Construction in Progress figures came in at $1.3 billion (Q4 2025), $1.4 billion (Q4 2024), and $1.1 billion (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.03 Bn | 39.83 Bn | 779.09 Mn | - |
| 2 | Zoetis | 30.51 Bn | 28.83 Bn | 1.05 Bn | - |
| 3 | Elanco Animal Health | 11.50 Bn | 10.97 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.48 Bn | 1.40 Bn | 134.40 Mn | - |
| 5 | Immucell | 89.38 Mn | 80.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 75.81 Mn | 68.71 Mn | - | 86,005.49 |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.30 Bn |
| Dec 31, 2024 | 1.35 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Dec 31, 2022 | 814.00 Mn |
| Dec 31, 2021 | 742.00 Mn |
| Dec 31, 2020 | 673.00 Mn |
| Dec 31, 2019 | 553.00 Mn |
| Dec 31, 2018 | 454.00 Mn |
| Dec 31, 2017 | 254.00 Mn |
| Dec 31, 2016 | 212.00 Mn |
| Dec 31, 2015 | 185.00 Mn |
| Dec 31, 2014 | 167.00 Mn |
| Dec 31, 2013 | 199.00 Mn |
| Dec 31, 2012 | 159.00 Mn |